$TNXP Stock – Upcoming milestones + Reverse split risk! – Due Diligence & Technical analysis

Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing drugs and biologics to treat various diseases. Its lead product candidate is TNX-102 SL, a proprietary cyclobenzaprine HCl sublingual tablets as a bedtime administration, which is in Phase III clinical trial for the treatment of posttraumatic stress disorder (PTSD) and… Read More »